West Virginia program
Comparable charges for chemo tablets and infusions
West Virginia limits how covered plans charge for oral cancer drugs compared with infused or injected treatment.
What it is
West Virginia limits how covered plans charge for oral cancer drugs compared with infused or injected treatment.
A move from an infusion to tablets changes how insurance bills the medicine. On a plan West Virginia regulates, the tablet's charges cannot be worse than the drip's, whatever benefit category the plan files it under; it is a comparison, not a dollar cap. A plan where the employer pays its own claims is outside the rule; HR can say which yours is.
Eligibility rules
- The group-policy rule applies to qualifying accident and sickness coverage under West Virginia law.
- The rule covers West Virginia group and individual policies. A public-employee (PEIA) plan or a private employer that pays claims itself needs a separate check; ask HR once.
What you get
- Oral anticancer cost sharing no less favorable than injected or infused anticancer cost sharing on covered plans.
What the protection covers
- The rule applies regardless of which benefit category the insurer uses for the drug.
- An actuarial exception can apply when the increase in total costs exceeds 2%, with the commissioner’s approval.
If you decide to apply
- Ask the pharmacy for the charge breakdown and the plan’s explanation of benefits.
- Ask the insurer to compare the oral and infused drug charges under the state parity rule.
- Ask the insurance commissioner to review whether the rule and any exception apply to your policy.
Offices of the Insurance Commissioner: 304-558-3386 · Official page ↗
After you ask
- The insurer reviews the cost-sharing comparison. The pharmacy’s payment details help show what the plan charged.
Good to know
A qualifying high-deductible plan applies the protection after the required minimum deductible. Comparable charges can still be expensive.
Other details
- The rule took effect for policy years beginning January 1, 2016. It is a parity requirement, not a fixed cap on the pharmacy bill.
Official sources
“If our child takes chemo by mouth, are the charges consistent with the infusion rules? Could you help check any deductible exception and challenge a charge if the protection applies?”
Why I’m asking: I want to understand whether a change in how treatment is given changes what we should owe.
More background and detailed requirements
Additional program information and published rules
Who does what
The three parts, side by side. The agency decides; nobody on this page does.
You
Compare the two charges and put the challenge in writing.
Your social worker
The pharmacy can print what the plan charged.
The care team
Nothing.
- Who decides
- The insurer, with the commissioner behind it.
- Ask your social worker
- “My child is moving to chemotherapy tablets. Can we check the plan is charging no more than it does for the infused kind?”
How to apply
First step: Compare the pharmacy charge with the infusion charge, and write to the plan if it is worse.
- Compare what the plan charges for the tablets against the infused treatment.
- If it is worse, write to the plan naming the state parity rule.
- If the plan says no, ask the insurance commissioner.
Official application / program page ↗
Where it starts: Tell the plan the state parity rule applies and ask for the cost sharing to be corrected.
What to gather
- The pharmacy receipt
- The plan's summary of benefits
- The infusion claim
How long: No clock; it changes what the plan can charge from the start.
What a yes looks like
The pharmacy charge dropping to match the medical benefit.
What a no looks like, and the next move
Ask whether the plan is claiming the actuarial exception, and take it to the commissioner.
Watch out
- It is a parity rule, not a price cap.
- A qualifying high-deductible plan applies it only after the minimum deductible.
- The individual article's wording is unresolved; ask the commissioner if you hold an individual policy.
The numbers and the rules
The arcane layer, kept on purpose. Checked September 11, 2026.
What it is worth
No worse copayment, deductible or coinsurance for chemotherapy taken by mouth than for the infused kind.
- $2 — Actuarial exception threshold for total cost increase
Legal protection: Cost sharing on oral anticancer medication cannot be less favourable than on injected or infused medication · The rule applies whatever benefit category the plan puts the drug in
What it costs the family: Nothing to claim; it changes what the plan can charge.
The eligibility facts, as published
- Plan scope
- group accident and sickness policies subject to the article; the individual article's applicability wording is unresolved
- Exceptions
- an actuarial cost-containment exception above two percent with the commissioner's approval, and a qualifying high-deductible plan applies it after the minimum deductible
Expect friction on: An actuarial exception exists where costs rise more than two percent · A qualifying high-deductible plan applies it only after the minimum deductible
The trap: This is a parity rule, not a dollar cap. It says the tablets cannot be treated worse than the drip; it does not promise a fixed price per fill.
Where I read this
- West Virginia Code 33-16-3x: oral anticancer parity, group policies — West Virginia Legislature, read September 10, 2026
- West Virginia Code 33-15-4l: oral anticancer parity, individual article — West Virginia Legislature, read September 10, 2026
- External review — West Virginia Offices of the Insurance Commissioner, read September 10, 2026